首页> 外国专利> 3-(31,51-DITERTBUTYL-41-HYDROXYPHENYL)-6,7-DIHYDRO-5H-PYROLYL1,2-AIMIDAZOLE HYDROCHLORIDE WITH ANTICANCER PROPERTIES

3-(31,51-DITERTBUTYL-41-HYDROXYPHENYL)-6,7-DIHYDRO-5H-PYROLYL1,2-AIMIDAZOLE HYDROCHLORIDE WITH ANTICANCER PROPERTIES

机译:3-(31,51-二叔丁基-41-羟基苯基)-6,7-二羟基-5H-吡咯[1,2-A]咪唑盐酸盐具有抗癌性

摘要

3-(31,51-ditertbutyl-41-hydroxyphenyl)-6,7-dihydro-5H-pyrolyl[1,2-a]imidazole hydrochloride with anticancer properties. This invention relates to organic and pharmaceutical chemistry and medicine, in particular pharmacologically active substances. This compound exhibits antitumor activity and can be used in the melanoma, renal cancer and breast cancer treatment. Investigation of antitumor activity is carried out in vitro on 60 cancer cell lines (leukemia, lung, colon, CNS, melanoma, ovarian, renal, prostate and breast cancer). The claimed compound at a concentration of 10-5 mol/l exhibits the ability to inhibit the growth of cancer cells, covering virtually the entire spectrum of human cancers. It is shown that compound is the most effective towards to melanoma cells SK-MeL-5 (-88,80%), kidney cancer cells RXF-393 (-53,31%) and breast cancer MDA-MB-468 (-21,31 %).
机译:具有抗癌特性的3-(31,51-二叔丁基-41-羟基苯基)-6,7-二氢-5H-吡咯基[1,2-a]咪唑盐酸盐。本发明涉及有机和药物化学与药物,特别是药理活性物质。该化合物具有抗肿瘤活性,可用于黑色素瘤,肾癌和乳腺癌的治疗。在60种癌细胞系(白血病,肺癌,结肠癌,中枢神经系统,黑色素瘤,卵巢癌,肾癌,前列腺癌和乳腺癌)上进行了抗肿瘤活性的体外研究。所要求保护的化合物的浓度为10-5 mol / l,具有抑制癌细胞生长的能力,几乎涵盖了人类癌症的整个范围。结果表明,该化合物对黑色素瘤细胞SK-MeL-5(-88,80%),肾癌细胞RXF-393(-53,31%)和乳腺癌MDA-MB-468(-21 ,31%)。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号